The purpose was to determine the effect of the timing of prophylactic antibiotics for cesarean section on post-operative infectious complications. STUDY DESIGN: This was a prospective, double-blinded, randomized controlled trial in which patients were randomized to receive cefazolin or clindamycin either before skin incision or after cord clamp. The primary outcome was maternal infectious morbidity at 6 weeks postpartum, a composite infectious outcome, which included endometritis, urinary tract infection, wound infection and pneumonia. RESULT: Data on 896 women were analyzed; 449 randomized to skin incision, 447 to cord clamp. Postpartum infections were seen in a total of 8.4% of patients. Timing of antibiotic administration did not significantly affect any maternal postpartum infection rates or selected neonatal outcomes. CONCLUSION: Our results suggest that, in a largely non-laboring population, the timing of prophylactic antibiotic administration does not impact post-operative infectious complications of the mother. Despite being one of the largest randomized controlled trials to address this question, our study still lacked sufficient power to make definitive conclusions.
INTRODUCTION
Cesarean section is the most common surgery performed in the United States, with B1.4 million cesareans performed annually. 1 Post-operative infections, such as surgical site infection and endometritis, have long been recognized as significant sources of post-operative morbidity associated with cesarean delivery. Several national organizations such as the Joint Commission and the Centers for Medicaid and Medicare Services have made tracking and prevention of post-operative infection a priority, using this performance measure as a means of assessing quality patient care (and potentially limiting reimbursement for those hospitals or surgeons with unacceptably high infection rates. ) Prophylactic antibiotics have been proven effective in the reduction of post-operative infection and have been the standard of care in cesarean deliveries for decades. 2 In the majority of surgical procedures, antibiotics are administered within 30 min of skin incision to confer the greatest benefit. 3 Yet, due to the nature of obstetrical practice in which there are two patients, the mother and the fetus, the situation with cesarean delivery is potentially more complicated. A study by Cunningham et al. 4 revealed that neonates exposed to antibiotics before delivery underwent more sepsis workups than those who were not exposed to antibiotics before delivery. 4 However, these results were biased as pediatricians were aware of the timing of the antibiotic exposure and often initiated the sepsis investigation based solely on timing, not on clinical symptomatology. Nonetheless, concern from neonatologists about antibiotics masking sepsis in the neonate caused obstetricians to shift their practice to administering antibiotics only after the umbilical cord had been clamped. Another more recent study showed that neonatal evaluations for possible sepsis are no different if the pediatrician or neonatologist is blinded to the timing of antibiotic administration. 5 Several studies since have been published on the timing of prophylactic antibiotic administration for cesarean delivery, but they had mixed results and many of the studies were underpowered. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] Therefore, the question of the importance of antibiotic timing in cesarean section still remains. Our study evaluates the timing of antibiotic administration in a large community hospital setting.
METHODS
Our study was a prospective double-blinded, randomized controlled trial conducted at St Vincent Hospital in Indianapolis, Indiana. The St Vincent Institutional Review Board approved the study in June 2006, and it was funded by a grant provided by the St Vincent Foundation (Grant no. 1-7175-1220701). All patients undergoing non-emergent cesarean section were offered enrollment, including patients with ruptured membranes and patients experiencing labor, as well as those who underwent scheduled cesarean deliveries. Exclusion criteria included the following: (1) fever greater than 38 1C, (2) age younger than 18 years, (3) diagnosis of chorioamnionitis before delivery, (4) allergy to both cefazolin and clindamycin and (5) exposure to any antibiotic within 1 week before delivery. Patients receiving penicillin for Group B streptococcus prophylaxis, however, were eligible for study inclusion.
Patient recruitment took place between September 2006 and January 2011. Informed consent was obtained for each patient by a resident on duty or the study principal investigator (EAS). Cesarean deliveries were performed by the resident on labor and delivery and the attending physician. Surgical technique and the type of skin closure were left to the discretion of the attending physician. Patients were transferred post-operatively to the postpartum unit and had an indwelling Foley catheter for B12 h.
Patients were randomized to receive the antibiotic either within 30 to 60 min of expected skin incision or after umbilical cord clamping. Two grams of intravenous Cefazolin was the primary antibiotic used, and clindamycin 900 mg was chosen for patients allergic to penicillin. Study drugs were instilled in 50 ml bags of saline, labeled either 'A' or 'B', and each patient received a 'bag A' before skin incision and a 'bag B' after cord clamp. One IV bag contained the antibiotic, and the other bag consisted of 50 cc of saline. The randomization sequence was generated by the hospital biostatistician. The randomization list was e-mailed to the research pharmacist, who was the only person with access to the randomization information for the duration of the study. Treatment assignment was performed in the pharmacy and all physicians and patients were blinded to which bag contained the antibiotic and which one had saline.
The primary outcome was maternal infectious morbidity which was a composite infectious outcome that included the presence of one or more of the following; wound infection, urinary tract infection (UTI), endometritis and pneumonia. Wound infection was determined by wound separation and purulent discharge, with or without associated fever (defined as oral temperature 438 1C on two separate occasions more than 6 h apart, after the initial 24-h post-operative period). UTI was defined as an abnormal urinalysis, positive urine culture and fever. Endometritis was identified by uterine tenderness, foul smelling lochia and fever. Pneumonia was diagnosed by symptoms (productive cough, chest pain with inspiration), fever, and chest X-ray findings. We elected to include pneumonia as an outcome to ensure comparability with the findings published by Thigpen et al.
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Patient demographic data consisting of age, race, body mass index at delivery, gestational age, gravidity, parity, history of previous cesarean, multiple pregnancy, tobacco use and diabetes were recorded. Operative time and antibiotic administration time, estimated blood loss and pre and post-operative hematocrit were also collected. Short-term infectious complications were identified in the hospital chart before discharge. Patients were also contacted at 6 weeks postpartum and questioned about infectious complications. Hospital records and postpartum office visits were also reviewed for post-op complications and readmission. Evaluation of the infectious morbidity was performed by two of the study co-investigators (CF, MM) who were masked to the group assignments. The presence or absence of an infection was based on both inpatient and postpartum data.
Although not powered for neonatal outcomes, data were collected regarding neonatal antibiotic administration, admission to the neonatal intensive care unit (NICU), and hospital readmission rates.
In planning the study, we estimated a 15% total post-operative infection rate based on the available literature. 8, 15 The number needed to achieve 80% power to detect a 33% difference in infectious complications was 1375 patients (roughly 688 per treatment group); this estimate was our original recruitment goal. Data were prospectively collected and analyzed using IBM SPSS Statistics, 19.0 (Chicago, IL, USA). Medians and interquartile ranges were used to summarize continuous data, and frequency distributions were used to summarize categorical data. Owing to the non-normal distribution of the continuous variables, comparisons were made using a Mann-Whitney U-test. Categorical variables were compared using a Fisher's exact test or Pearson's w 2 -test, as appropriate. Significance levels were set at ao0.05.
RESULTS
A total of 897 patients were randomized, one patient was excluded due to lack of access to her medical information, leaving a total of 896 patients available for analysis. Four hundred forty-nine patients (50.1%) received antibiotics before skin incision and 447 patients (49.9%) received antibiotics at cord clamp. Ninety-five women (10.6%) were lost to follow-up; therefore data on only 801 women are included in the final analysis. Of the 95 women lost to follow-up, 39 (4.4%) were in the skin incision group and 56 (6.2%) were in the cord clamp group (P ¼ 0.066). There was not a statistically significant difference between the women lost to follow-up in regards to demographic or delivery data (PX0.05; data not shown).
Demographic data by group are shown in Table 1 . The groups were similar with regards to maternal age, gestational age, gravidity, parity, history of cesarean section and labor induction. Factors that affect post-operative infectious risk, such as diabetes, tobacco use, group B strep status and body mass index at delivery were also similar between the groups. There were no statistically significant differences between the groups in the following factors: operative time, estimated blood loss, and time of ruptured membranes ( Table 2) . Indications for cesarean delivery were also distributed similarly in the two study groups (Table 2 ,
The primary outcome, postpartum infection, occurred in 67 of 801 women (8.4%) Wound infection was the most common complication with a rate of 4.9% and pneumonia the least common with a rate of 0.4%. As shown in Table 3 , there was no statistically significant difference between the skin incision and cord clamp groups for any of the postpartum infection rates. Infection rates for wound infections and endometritis were higher in the cord clamp group; but, the difference was not statistically significant. Most events (69.1%) occurred after hospital discharge and post-discharge infections were equally likely to occur in the skin incision group as in the cord clamp group (70.0% vs 68.4%, respectively; P ¼ 0.889). A total of 84 (10.5%) women were prescribed an antibiotic in the postpartum period; 38 (4.7%) in the skin incision group and 46 (5.7%) in the cord clamp group (P ¼ 0.249). Seventeen of the women receiving antibiotics were deemed to have an infection unrelated to the purpose of this study, such as mastitis and otitis media.
The two study groups were also analyzed after eliminating patients who had received penicillin for Group B streptococcus prophylaxis, to ensure the results had not been biased by predelivery penicillin exposure. In this smaller sub sample, there were no statistically significant differences in infectious outcomes (data not shown).
Notably, the majority of patients who were enrolled in the study had a scheduled cesarean delivery; only 23.0% of enrolled patients labored before their cesarean delivery. For this reason, the infectious outcomes of the laboring patients were analyzed separately. Not surprisingly, the total infection rate was higher for laboring patients than that in the general study group (10.8% vs 7.6%), but the difference was not statistically significant (P ¼ 0.175). Although the rates were higher for the laboring patients, there was no statistically significant difference in rates of wound infection (6.0% vs 4.6%; P ¼ 0.436), endometritis (2.2% vs 1.0%; P ¼ 0.250), pneumonia (0% vs 0.5%; P ¼ 1.000), or UTI (2.7% vs 1.8%; P ¼ 0.386) between the groups. Comparison of infection rates for laboring patients by timing of antibiotic also found no statistically significant difference in the primary (P ¼ 1.000) and secondary outcomes (wound infection P ¼ 0.767, endometritis P ¼ 0.368, UTI P ¼ 0.368, no incidence of pneumonia).
There were no significant differences in selected neonatal outcomes between the skin incision and cord clamp groups including: NICU admission (13.4% vs 15.2%, respectively; P ¼ 0.446), antibiotic administration (6.7% vs 7.6%, respectively; P ¼ 0.606), NICU readmission within 72 h (0.7% vs 1.1%, respectively; P ¼ 0.505) or NICU readmission within 6 weeks (2.9% vs 2.3%, respectively; P ¼ 0.661).
DISCUSSION
Results of our randomized control trial suggest that the timing of prophylactic antibiotic administration at cesarean, before skin incision compared with after umbilical cord clamp, may not significantly influence the occurrence of total (composite) maternal postpartum infections. Similar results were found when we looked at rates of wound infection, endometritis and UTI. However, these findings may be due to the study being underpowered. The timing of antibiotic administration had no significant effect on neonatal outcomes, but our study was not powered to detect neonatal outcomes.
The major strength of this study is that it represents the largest prospective, randomized, double-blinded, placebo-controlled study in the literature to date. Patients, obstetricians and pediatricians were all blinded to the timing of the antibiotic administration. We enrolled both laboring and non-laboring patients so that our study population would be more consistent with the general obstetric population than previous studies, which often included only one of those groups. We did recruit more nonlaboring patients, which may have been a function of the logistical ease of consenting these patients.
Weaknesses include our inability to enroll the number of patients we originally planned and the lower than expected infection rate, which resulted in an insufficiently powered study. Based on our infection rate and sample size, our study had 57% power to detect a significant difference in total (composite) infection rate between the groups. The logistics of our patient recruitment (on labor and delivery at the time of surgery) resulted in a larger than expected portion of enrolled patients having scheduled cesarean deliveries. These patients are known to have a Prophylactic antibiotics in cesarean section C Francis et al lower rate of infection, which may have limited our ability to determine a true difference in infection rates between the two groups. In addition, patient recruitment was the responsibility of residents and attendings, who were often busy with clinical care and did not have sufficient time to do the recruiting and consenting. Given that very few patients approached about the study refused and only three of the community physicians opted out, employing research personnel to assist with recruitment may have increased our potential enrollment. An additional unforeseen barrier to recruitment was that the momentum for enrollment waned following the publication of Costantine et al.'s 16 metaanalysis in 2008, which showed a 50% decrease in post-operative infectious complications when antibiotics were given before skin incision and the American College of Obstetricians Gynecologists Committee Opinion in 2010, advocating that all patients undergoing a cesarean delivery be given appropriate antibiotic therapy before skin incision. 17 Despite our difficulties with enrollment, our study is still the largest randomized trial to address this question. Our results suggest that in a largely non-laboring population, the timing of prophylactic antibiotic administration does not benefit the mother or infant. Since the publication of the meta-analysis by Costantine et al., 16 two other randomized controlled trials addressing the timing of antibiotic administration at cesarean, have been published. 13, 14 Both these studies did not find a significant difference in infection rate between the groups.
The debate on the timing of antibiotic administration at cesarean has emerged in the last several years with the publication of several observational studies, 6, 9, 11 clinical trials, 5, 7, 8, 10, [12] [13] [14] 18 a review article, 19 and meta-analyses. 16, 20 These results culminated in American College of Obstetricians Gynecologists issuing a Committee Opinion advocating that all women undergoing a cesarean delivery be given prophylactic antibiotics before skin incision, 17 and the National Institute for Health and Clinical Excellence advising clinicians to offer prophylactic antibiotics at cesarean before skin incision. 20 Although our study was underpowered to determine our primary endpoint, the observed decreases in endometritis (33%) and wound infection (31%) would seem to support the American College of Obstetricians Gynecologists's recommendation for administration of antibiotics before skin incision. Remaining questions about neonatal outcomes will necessarily await a much larger randomized trial or further meta-analysis of existing trials.
